Latest News » Curcumin linked to promising new lung cancer treatments

Curcumin, the active ingredient in turmeric, could be utilized to fight lung cancer.

Lung cancer is one of the toughest diseases to fight due to the frequently overlooked diagnosis, slow-building symptoms and an overall poor prognosis once treatment begins. However, a new study published in the International Journal of Oncology suggests that curcumin, the active ingredient found in turmeric, could contain properties that promote a more beneficial form of treatment for lung cancer patients.

Phospho-sulindac (PS), according to the research team, is an effective method of fighting colon cancer, and the group sought to establish whether or not the chemical would be applicable to lung cancer growths. They turned to curcumin to see whether or not it could enhance the use of PS, as it has with other forms of the progressive disease. 

Using a mice-based study method, the scientists determined that the curcumin-infused treatments "enhanced the cellular update of PS in human lung and colon cancer cell lines," meaning that the application of curcumin made it easier for the test subjects' bodies to receive the dosage more effectively.

"Our results show that curcumin substantially improves the pharmacokinetics of PS leading to synergistic inhibition of the growth of human lung cancer xenografts, representing a promising drug combination," the study's abstract stated.

This is not the first time that curcumin has been utilized to fight cancer more effectively. Not only has evidence shown that the nutrient has anti-inflammatory capabilities, but in some cases, it has actually been seen reducing or even eliminating the metastatic of existing cancers. More research is sure to be conducted in this field as the fight against cancer continues to evolve.

You can click here to read information about Nutrivene Longvida Curcumin.